These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17914247)

  • 21. Oxidative stress in young Zucker rats with impaired glucose tolerance is diminished by acarbose.
    Rösen P; Osmers A
    Horm Metab Res; 2006 Sep; 38(9):575-86. PubMed ID: 16981139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.
    Giunti S; Calkin AC; Forbes JM; Allen TJ; Thomas MC; Cooper ME; Jandeleit-Dahm KA
    Am J Physiol Renal Physiol; 2010 Sep; 299(3):F528-35. PubMed ID: 20554645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rosuvastatin suppresses the oxidative response in the venous limb of an arteriovenous fistula and enhances the fistula blood flow in diabetic rats.
    Fang SY; Roan JN; Lin Y; Hsu CH; Chang SW; Huang CC; Tsai YC; Lam CF
    J Vasc Res; 2014; 51(2):81-9. PubMed ID: 24434545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro anti-oxidant and DNA protective effects of the novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin.
    Ajith TA; Riji T; Anu V
    Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):625-9. PubMed ID: 18177480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus.
    Schäfer A; Fraccarollo D; Vogt C; Flierl U; Hemberger M; Tas P; Ertl G; Bauersachs J
    Biochem Pharmacol; 2007 May; 73(9):1367-75. PubMed ID: 17270148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose.
    Kostapanos MS; Milionis HJ; Agouridis AD; Rizos CV; Elisaf MS
    Int J Clin Pract; 2009 Sep; 63(9):1308-13. PubMed ID: 19691613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of rosuvastatin on ADMA, rhokinase, NADPH oxidase, caveolin-1, hsp 90 and NFkB levels in a rat model of myocardial ischaemia-reperfusion.
    Burma O; Onat E; Uysal A; Ilhan N; Erol D; Ozcan M; Sahna E
    Cardiovasc J Afr; 2014; 25(5):212-6. PubMed ID: 25629537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.
    Habibi J; Whaley-Connell A; Qazi MA; Hayden MR; Cooper SA; Tramontano A; Thyfault J; Stump C; Ferrario C; Muniyappa R; Sowers JR
    Endocrinology; 2007 May; 148(5):2181-8. PubMed ID: 17317778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatty liver and insulin resistance in obese Zucker rats: no role for mitochondrial dysfunction.
    Flamment M; Arvier M; Gallois Y; Simard G; Malthièry Y; Ritz P; Ducluzeau PH
    Biochimie; 2008 Sep; 90(9):1407-13. PubMed ID: 18534199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats.
    Loch D; Levick S; Hoey A; Brown L
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):396-404. PubMed ID: 16633082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antioxidant and antiplatelet effects of rosuvastatin in a hamster model of prediabetes.
    Miersch S; Sliskovic I; Raturi A; Mutus B
    Free Radic Biol Med; 2007 Jan; 42(2):270-9. PubMed ID: 17189832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Podocyte lesions in patients with obesity-related glomerulopathy.
    Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS
    Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metallothionein over-expression in podocytes reduces adriamycin nephrotoxicity.
    Yang L; Zheng S; Epstein PN
    Free Radic Res; 2009 Feb; 43(2):174-82. PubMed ID: 19204870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on the effect and mechanism of ascorbic acid on renal podocytes in diabetes].
    Qin QJ; Deng HC; Zhao TF; Cao WF; Liu DF; Lan LZ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):112-5. PubMed ID: 21141572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rosuvastatin improves insulin sensitivity in overweight rats induced by high fat diet. Role of SIRT1 in adipose tissue].
    Valero-Muñoz M; Martín-Fernández B; Ballesteros S; Cachofeiro V; Lahera V; de Las Heras N
    Clin Investig Arterioscler; 2014; 26(4):161-7. PubMed ID: 24612843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rosuvastatin reduces platelet recruitment by inhibiting NADPH oxidase activation.
    Pignatelli P; Carnevale R; Di Santo S; Bartimoccia S; Nocella C; Vicario T; Loffredo L; Angelico F; Violi F
    Biochem Pharmacol; 2012 Dec; 84(12):1635-42. PubMed ID: 23022230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins ameliorate glomerular permeability changes in streptozotocin-induced diabetic rats.
    Mooradian AD; Haas MJ
    Am J Ther; 2007; 14(1):41-5. PubMed ID: 17303974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy.
    Tomohiro T; Kumai T; Sato T; Takeba Y; Kobayashi S; Kimura K
    Life Sci; 2007 Mar; 80(15):1364-72. PubMed ID: 17331548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.
    Guo H; Shi Y; Liu L; Sun A; Xu F; Chi J
    Arch Med Res; 2009 Jul; 40(5):345-51. PubMed ID: 19766896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective albuminuria via podocyte albumin transport in puromycin nephrotic rats is attenuated by an inhibitor of NADPH oxidase.
    Kinugasa S; Tojo A; Sakai T; Tsumura H; Takahashi M; Hirata Y; Fujita T
    Kidney Int; 2011 Dec; 80(12):1328-38. PubMed ID: 21849973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.